Working… Menu

Hypofractionated Radiotherapy (Stereotactic) Versus Conventional Radiotherapy for Inoperable Early Stage I Non-small Cell Lung Cancer (NSCLC) (CHISEL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01014130
Recruitment Status : Unknown
Verified July 2017 by Trans Tasman Radiation Oncology Group.
Recruitment status was:  Active, not recruiting
First Posted : November 16, 2009
Last Update Posted : July 12, 2017
Information provided by (Responsible Party):
Trans Tasman Radiation Oncology Group